124 related articles for article (PubMed ID: 2531377)
1. Endopeptidase-24.11 in human plasma degrades atrial natriuretic factor (ANF) to ANF(99-105/106-126).
Yandle TG; Brennan SO; Espiner EA; Nicholls MG; Richards AM
Peptides; 1989; 10(4):891-4. PubMed ID: 2531377
[TBL] [Abstract][Full Text] [Related]
2. Degradation of atrial natriuretic peptides by an enzyme in rat kidney resembling neutral endopeptidase 24.11.
Bertrand P; Doble A
Biochem Pharmacol; 1988 Oct; 37(20):3817-21. PubMed ID: 2973321
[TBL] [Abstract][Full Text] [Related]
3. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
Marleau S; Nguyen TT; Du Souich P; Bellemare M; De Lean A; Ong H
Drug Metab Dispos; 1991; 19(1):194-9. PubMed ID: 1673398
[TBL] [Abstract][Full Text] [Related]
4. Bivariate assay for cleaved atrial natriuretic factor (ANF(101-105/106-126)) in sheep plasma.
Yandle T; Sadler B; Charles C; Espiner E; Richards M
Regul Pept; 1992 Aug; 40(3):389-96. PubMed ID: 1438981
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of atrial natriuretic factor by the renal brush border.
Olins GM; Spear KL; Siegel NR; Zurcher-Neely HA
Biochim Biophys Acta; 1987 Jul; 901(1):97-100. PubMed ID: 2954587
[TBL] [Abstract][Full Text] [Related]
6. Degradation of atrial natriuretic factor by kidney cortex membranes. Isolation and characterization of the primary proteolytic product.
Koehn JA; Norman JA; Jones BN; LeSueur L; Sakane Y; Ghai RD
J Biol Chem; 1987 Aug; 262(24):11623-7. PubMed ID: 2957371
[TBL] [Abstract][Full Text] [Related]
7. Biological actions of cleaved atrial natriuretic factor (ANF101-105/106-126) in conscious sheep.
Charles CJ; Espiner EA; Yandle TG; Cameron VA; Richards AM
J Cardiovasc Pharmacol; 1991 Mar; 17(3):403-10. PubMed ID: 1711601
[TBL] [Abstract][Full Text] [Related]
8. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543
[TBL] [Abstract][Full Text] [Related]
9. Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor.
Okolicany J; McEnroe GA; Koh GY; Lewicki JA; Maack T
Am J Physiol; 1992 Sep; 263(3 Pt 2):F546-53. PubMed ID: 1415584
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.
Barclay PL; Bennett JA; Greengrass PM; Griffin A; Samuels GM; Shepperson NB
Biochem Pharmacol; 1992 Sep; 44(6):1013-22. PubMed ID: 1417928
[TBL] [Abstract][Full Text] [Related]
11. Degradation and inactivation of human atrial natriuretic peptide by human pulmonary plasma membranes.
Lindberg BF; Andersson KE
Regul Pept; 1993 Aug; 47(1):53-63. PubMed ID: 8210521
[TBL] [Abstract][Full Text] [Related]
12. The hydrolysis of brain and atrial natriuretic peptides by porcine choroid plexus is attributable to endopeptidase-24.11.
Bourne A; Kenny AJ
Biochem J; 1990 Oct; 271(2):381-5. PubMed ID: 2146950
[TBL] [Abstract][Full Text] [Related]
13. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats.
Chiu PJ; Tetzloff G; Romano MT; Foster CJ; Sybertz EJ
Am J Physiol; 1991 Jan; 260(1 Pt 2):R208-16. PubMed ID: 1847022
[TBL] [Abstract][Full Text] [Related]
14. Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney.
Sonnenberg JL; Sakane Y; Jeng AY; Koehn JA; Ansell JA; Wennogle LP; Ghai RD
Peptides; 1988; 9(1):173-80. PubMed ID: 2966343
[TBL] [Abstract][Full Text] [Related]
15. Fast atom bombardment mass spectrometric investigation of in vitro degradation within the disulfide-linked core of atrial natriuretic factor.
Chen TM; Ackermann BL; Coutant JE; Berman JM; Pelton JT
Biomed Environ Mass Spectrom; 1989 Jan; 18(1):12-9. PubMed ID: 2523232
[TBL] [Abstract][Full Text] [Related]
16. NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life.
Thibault G; Murthy KK; Gutkowska J; Seidah NG; Lazure C; Chrétien M; Cantin M
Peptides; 1988; 9(1):47-53. PubMed ID: 2966345
[TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site.
Vanneste Y; Michel A; Dimaline R; Najdovski T; Deschodt-Lanckman M
Biochem J; 1988 Sep; 254(2):531-7. PubMed ID: 2972276
[TBL] [Abstract][Full Text] [Related]
18. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
19. ANF (99-126) and its propeptide, ANF (1-16) are secreted simultaneously from the human atrial myocyte.
Lindop GB; Mallon EA; Hair J; Downie TT; MacIntyre G
J Hypertens; 1987 Oct; 5(5):533-6. PubMed ID: 2963063
[TBL] [Abstract][Full Text] [Related]
20. The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure.
Winters CJ; Sallman AL; Baker BJ; Meadows J; Rico DM; Vesely DL
Circulation; 1989 Sep; 80(3):438-49. PubMed ID: 2527642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
